scholarly journals MICROFLUIDIC DEVICES FOR RAPID LABEL-FREE SEPARATION OF CELLS AND POINT-OF-CARE DIAGNOSTICS

2012 ◽  
Author(s):  
S. Bose ◽  
M.-H. Hollatz ◽  
C.-H. Lee ◽  
J.M. Karp ◽  
R. Karnik
Keyword(s):  
Point Of Care ◽  
Microfluidic Devices ◽  
Label Free ◽  
Point Of Care Diagnostics

scholarly journals Microfluidics-Based Plasmonic Biosensing System Based on Patterned Plasmonic Nanostructure Arrays

Micromachines ◽  
2021 ◽  
Vol 12 (7) ◽  
pp. 826
Author(s):  
Yanting Liu ◽  
Xuming Zhang
Keyword(s):  
Plasmon Resonance ◽  
Point Of Care ◽  
Simultaneous Detection ◽  
High Sensitivity ◽  
Microfluidic Chips ◽  
Label Free ◽  
Plasmonic Nanostructure ◽  
Point Of Care Diagnostics ◽  
Surface Enhanced Raman ◽  
Nanostructure Arrays

This review aims to summarize the recent advances and progress of plasmonic biosensors based on patterned plasmonic nanostructure arrays that are integrated with microfluidic chips for various biomedical detection applications. The plasmonic biosensors have made rapid progress in miniaturization sensors with greatly enhanced performance through the continuous advances in plasmon resonance techniques such as surface plasmon resonance (SPR) and localized SPR (LSPR)-based refractive index sensing, SPR imaging (SPRi), and surface-enhanced Raman scattering (SERS). Meanwhile, microfluidic integration promotes multiplexing opportunities for the plasmonic biosensors in the simultaneous detection of multiple analytes. Particularly, different types of microfluidic-integrated plasmonic biosensor systems based on versatile patterned plasmonic nanostructured arrays were reviewed comprehensively, including their methods and relevant typical works. The microfluidics-based plasmonic biosensors provide a high-throughput platform for the biochemical molecular analysis with the advantages such as ultra-high sensitivity, label-free, and real time performance; thus, they continue to benefit the existing and emerging applications of biomedical studies, chemical analyses, and point-of-care diagnostics.

scholarly journals Polysaccharide Multilayer Films in Sensors for Detecting Prostate Tumor Cells Based on Hyaluronan-CD44 Interactions

Cells ◽  
2020 ◽  
Vol 9 (6) ◽  
pp. 1563 ◽  
Author(s):  
João Batista Maia Rocha Neto ◽  
Andrey Coatrini Soares ◽  
Rogério Aparecido Bataglioli ◽  
Olívia Carr ◽  
Carlos Alberto Rodrigues Costa ◽  
...  
Keyword(s):  
Tumor Cells ◽  
Point Of Care ◽  
Prostate Tumor ◽  
Layer By Layer ◽  
Label Free ◽  
Point Of Care Diagnostics ◽  
Lbl Films ◽  
Prostatic Tumor ◽  
Prostate Tumor Cells

The increasing need for point-of-care diagnosis has sparked the development of label-free sensing platforms, some of which are based on impedance measurements with biological cells. Here, interdigitated electrodes were functionalized with layer-by-layer (LbL) films of hyaluronan (HA) and chitosan (CHI) to detect prostatic tumor cells (PC3 line). The deposition of LbL films was confirmed with atomic force microscopy and polarization-modulated infrared reflection absorption spectroscopy (PM-IRRAS), which featured the vibrational modes of the HA top layer capable of interacting specifically with glycoprotein CD44 receptors overexpressed in tumor cells. Though the CHI/HA LbL films cannot be considered as a traditional biosensor due to their limited selectivity, it was possible to distinguish prostate tumor cells in the range from 50 to 600 cells/µL in in vitro experiments with impedance spectroscopy. This was achieved by treating the impedance data with information visualization methods, which confirmed the distinguishing ability of the films by observing the absence of false positives in a series of control experiments. The CD44–HA interactions may, therefore, be exploited in clinical analyses and point-of-care diagnostics for cancer, particularly if computational methods are used to process the data.

Label-Free and Recalibrated Multilayer MoS2 Biosensor for Point-of-Care Diagnostics

2017 ◽  
Vol 9 (50) ◽  
pp. 43490-43497 ◽  
Author(s):  
Heekyeong Park ◽  
Gyuchull Han ◽  
Sang Woo Lee ◽  
Hyungbeen Lee ◽  
Seok Hwan Jeong ◽  
...  
Keyword(s):  
Point Of Care ◽  
Label Free ◽  
Point Of Care Diagnostics

scholarly journals Conventional and emerging strategies for the fabrication and functionalization of PDMS-based microfluidic devices

Lab on a Chip ◽  
2021 ◽  
Author(s):  
Amid Shakeri ◽  
Shadman Khan ◽  
Tohid Fatanat Didar
Keyword(s):  
Point Of Care ◽  
Microfluidic Devices ◽  
Point Of Care Diagnostics

Microfluidics is an emerging and multidisciplinary field that is of great interest to manufacturers in medicine, biotechnology, and chemistry, as it provides unique tools for the development of point-of-care diagnostics,...

Plasmonic and label-free real-time quantitative PCR for point-of-care diagnostics

The Analyst ◽  
2021 ◽  
Author(s):  
Padideh Mohammadyousef ◽  
Miltiadis Paliouras ◽  
Mark Trifiro ◽  
Andrew Kirk
Keyword(s):  
Pathogen Detection ◽  
Point Of Care ◽  
Medical Community ◽  
Molecular Diagnostic ◽  
Label Free ◽  
Chain Reaction ◽  
Real Time Quantitative Pcr ◽  
Point Of Care Diagnostics ◽  
Polymerase Chain ◽  
Infectious Pathogen

In response to the world’s medical community need for accurate and immediate infectious pathogen detection, many researchers have focused on adapting the standard molecular diagnostic method of polymerase chain reaction...

scholarly journals Label-free plasmonic biosensors for point-of-care diagnostics: a review

2018 ◽  
Vol 19 (1) ◽  
pp. 71-81 ◽  
Author(s):  
Maria Soler ◽  
Cesar S. Huertas ◽  
Laura M. Lechuga
Keyword(s):  
Point Of Care ◽  
Label Free ◽  
Point Of Care Diagnostics

scholarly journals Utilizing Continuous Flow Microdevices-based Magnetophoresis for COVID-19 Diagnosis

2020 ◽  
Vol 11 (4) ◽  
pp. 11996-12005
Keyword(s):  
Continuous Flow ◽  
Preventive Measures ◽  
Point Of Care ◽  
Microfluidic Devices ◽  
Therapeutic Approaches ◽  
Biological Structure ◽  
Point Of Care Diagnostics ◽  
Travel Restrictions ◽  
Future Potential ◽  
First Time

The contagious disease called COVID-19 is caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Several precautionary and preventive measures are currently implemented, including travel restrictions, health quarantine, and medical care. However, no explicit treatments are available. Thus, a better understanding of the new infectious disease's nature and the contributing virus is required. This article will briefly review the biological structure and mechanism of the SARS-CoV-2, comparing it to other known coronaviruses, and the potential therapeutic approaches currently under investigation, and propose for the first time the utilization of microfluidic devices based magnetophoresis for SARS-CoV-2 detection and point of care diagnostics as a future potential effective method.

Sign in / Sign up

Export Citation Format

Share Document